<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Owusu DO</submitter><funding>Deutsche Forschungsgemeinschaft</funding><pagination>855</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10146292</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>&lt;i>Mycobacterium (M.) bovis&lt;/i> BCG vaccination is recommended for healthy babies after birth in several countries with a high prevalence of tuberculosis, including Ghana. Previous studies showed that BCG vaccination prevents individuals from developing severe clinical manifestations of tuberculosis, but BCG vaccination effects on the induction of IFN-γ after &lt;i>M. tuberculosis&lt;/i> infection have hardly been investigated. Here, we performed IFN-γ-based T-cell assays (i.e., IFN-γ Release Assay, IGRA; T-cell activation and maturation marker assay, TAM-TB) in children who had contact with index tuberculosis patients (contacts). These contacts were classified as either being BCG vaccinated at birth (&lt;i>n&lt;/i> = 77) or non-BCG-vaccinated (&lt;i>n&lt;/i> = 17) and were followed up at three timepoints f</pubmed_abstract><journal>Vaccines</journal><pubmed_title>BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of &lt;i>Mycobacterium tuberculosis&lt;/i>-Specific IFN-γ Release.</pubmed_title><pmcid>PMC10146292</pmcid><funding_grant_id>JA 1479/9-1</funding_grant_id><pubmed_authors>Abass MK</pubmed_authors><pubmed_authors>Mayatepek E</pubmed_authors><pubmed_authors>Yeboah A</pubmed_authors><pubmed_authors>Acheampong I</pubmed_authors><pubmed_authors>Batsa Debrah L</pubmed_authors><pubmed_authors>Jacobsen M</pubmed_authors><pubmed_authors>Lamptey M</pubmed_authors><pubmed_authors>Kumbel F</pubmed_authors><pubmed_authors>Phillips RO</pubmed_authors><pubmed_authors>Osei-Yeboah F</pubmed_authors><pubmed_authors>Arthur JF</pubmed_authors><pubmed_authors>Debrah A</pubmed_authors><pubmed_authors>Owusu DO</pubmed_authors><pubmed_authors>Seyfarth J</pubmed_authors><pubmed_authors>Aniagyei W</pubmed_authors><pubmed_authors>Minadzi D</pubmed_authors><pubmed_authors>Adankwah E</pubmed_authors><pubmed_authors>Vivekanandan MM</pubmed_authors><pubmed_authors>Gawusu A</pubmed_authors></additional><is_claimable>false</is_claimable><name>BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of &lt;i>Mycobacterium tuberculosis&lt;/i>-Specific IFN-γ Release.</name><description>&lt;i>Mycobacterium (M.) bovis&lt;/i> BCG vaccination is recommended for healthy babies after birth in several countries with a high prevalence of tuberculosis, including Ghana. Previous studies showed that BCG vaccination prevents individuals from developing severe clinical manifestations of tuberculosis, but BCG vaccination effects on the induction of IFN-γ after &lt;i>M. tuberculosis&lt;/i> infection have hardly been investigated. Here, we performed IFN-γ-based T-cell assays (i.e., IFN-γ Release Assay, IGRA; T-cell activation and maturation marker assay, TAM-TB) in children who had contact with index tuberculosis patients (contacts). These contacts were classified as either being BCG vaccinated at birth (&lt;i>n&lt;/i> = 77) or non-BCG-vaccinated (&lt;i>n&lt;/i> = 17) and were followed up at three timepoints f</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-05T10:01:42.935Z</modification><creation>2025-04-05T10:01:42.935Z</creation></dates><accession>S-EPMC10146292</accession><cross_references><pubmed>37112767</pubmed><doi>10.3390/vaccines11040855</doi></cross_references></HashMap>